Comparison and fine mapping of both high and low neutralizing monoclonal antibodies against the principal neutralization domain of HIV-1 - PubMed (original) (raw)
Comparative Study
doi: 10.1007/BF01309690.
Affiliations
- PMID: 1381908
- DOI: 10.1007/BF01309690
Comparative Study
Comparison and fine mapping of both high and low neutralizing monoclonal antibodies against the principal neutralization domain of HIV-1
J P Langedijk et al. Arch Virol. 1992.
Abstract
Monoclonal antibodies raised against viral lysate of HIV-1 (strain LAV-1) and against recombinant gp 160 of HIV-1 (strain HTLV IIIB) which neutralized HIV-1 in a type specific manner were mapped with the aid of peptides (Pepscan analysis). Each of these monoclonal antibodies bound to peptides located on the principal neutralizing domain (PND) of HIV-1. We found that the antigenic sites of the MAbs described in this paper are represented by linear peptides of at least 10 amino acids long. The affinity of the MAbs is high for these peptides and in the same order of magnitude as for native gp 160. The fine mapping of the epitopes may reflect structural features of the PND, for instance which amino acid side chains are exposed and which are buried in the protein. Furthermore the fine mapping of the epitopes explained the HIV type-specific neutralizing activity of the MAbs. Antibodies that bound to the tip of the loop (amino acids QRGPGRAF) have a higher neutralizing activity than antibodies that bound to amino acids towards the N-terminal side of the loop (amino acids KSIRI). Furthermore, MAbs that bound to virtually the same amino acids on the tip of the loop (amino acids IQRGPGRAF and RGPGRAFV) had different neutralizing activities due to different affinities for native gp 160. These data reveal that neutralizing activity not only is determined by the affinity of an antibody to the neutralizing site but also by its fine binding specificities to the V 3 loop of gp 120.
Similar articles
- Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120.
Akerblom L, Hinkula J, Broliden PA, Mäkitalo B, Fridberger T, Rosen J, Villacres-Eriksson M, Morein B, Wahren B. Akerblom L, et al. AIDS. 1990 Oct;4(10):953-60. doi: 10.1097/00002030-199010000-00002. AIDS. 1990. PMID: 1702001 - Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
D'Souza MP, Geyer SJ, Hanson CV, Hendry RM, Milman G. D'Souza MP, et al. AIDS. 1994 Feb;8(2):169-81. AIDS. 1994. PMID: 7519019 - Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160.
Benjouad A, Gluckman JC, Montagnier L, Bahraoui E. Benjouad A, et al. J Virol. 1993 Mar;67(3):1693-7. doi: 10.1128/JVI.67.3.1693-1697.1993. J Virol. 1993. PMID: 7679751 Free PMC article. - Two neutralizing domains in the V3 region in the envelope glycoprotein gp125 of HIV type 2.
Björling E, Chiodi F, Utter G, Norrby E. Björling E, et al. J Immunol. 1994 Feb 15;152(4):1952-9. J Immunol. 1994. PMID: 8120399
Cited by
- The v3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope.
Gorny MK, Revesz K, Williams C, Volsky B, Louder MK, Anyangwe CA, Krachmarov C, Kayman SC, Pinter A, Nadas A, Nyambi PN, Mascola JR, Zolla-Pazner S. Gorny MK, et al. J Virol. 2004 Mar;78(5):2394-404. doi: 10.1128/jvi.78.5.2394-2404.2004. J Virol. 2004. PMID: 14963135 Free PMC article. - Posttranslational processing and identification of a neutralization domain of the GP4 protein encoded by ORF4 of Lelystad virus.
Meulenberg JJ, van Nieuwstadt AP, van Essen-Zandbergen A, Langeveld JP. Meulenberg JJ, et al. J Virol. 1997 Aug;71(8):6061-7. doi: 10.1128/JVI.71.8.6061-6067.1997. J Virol. 1997. PMID: 9223499 Free PMC article. - Antigenic structure of the central conserved region of protein G of bovine respiratory syncytial virus.
Langedijk JP, Meloen RH, Taylor G, Furze JM, van Oirschot JT. Langedijk JP, et al. J Virol. 1997 May;71(5):4055-61. doi: 10.1128/JVI.71.5.4055-4061.1997. J Virol. 1997. PMID: 9094683 Free PMC article. - Fine mapping of outer membrane protein P2 antigenic sites which vary during persistent infection by Haemophilus influenzae.
Duim B, Vogel L, Puijk W, Jansen HM, Meloen RH, Dankert J, van Alphen L. Duim B, et al. Infect Immun. 1996 Nov;64(11):4673-9. doi: 10.1128/iai.64.11.4673-4679.1996. Infect Immun. 1996. PMID: 8890224 Free PMC article. - Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein.
Moore JP, Sodroski J. Moore JP, et al. J Virol. 1996 Mar;70(3):1863-72. doi: 10.1128/JVI.70.3.1863-1872.1996. J Virol. 1996. PMID: 8627711 Free PMC article.
References
- Cell. 1988 Mar 11;52(5):631-3 - PubMed
- Nature. 1990 Jan 18;343(6255):219 - PubMed
- J Immunol Methods. 1982 Aug 27;53(1):103-8 - PubMed
- J Med Virol. 1990 Jul;31(3):200-8 - PubMed
- AIDS Res Hum Retroviruses. 1988 Jun;4(3):187-97 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources